- Home
- BWAY vs OLMA Comparison
BWAY vs OLMA Comparison
Compare BWAY & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- OLMA
- Stock Information
- Founded
- BWAY 2003
- OLMA 2006
- Country
- BWAY Israel
- OLMA United States
- Employees
- BWAY N/A
- OLMA N/A
- Industry
- BWAY Medical/Dental Instruments
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- BWAY Health Care
- OLMA Health Care
- Exchange
- BWAY Nasdaq
- OLMA Nasdaq
- Market Cap
- BWAY 280.7M
- OLMA 299.7M
- IPO Year
- BWAY 2019
- OLMA 2020
- Fundamental
- Price
- BWAY $15.20
- OLMA $5.76
- Analyst Decision
- BWAY Strong Buy
- OLMA Strong Buy
- Analyst Count
- BWAY 2
- OLMA 5
- Target Price
- BWAY $18.00
- OLMA $24.00
- AVG Volume (30 Days)
- BWAY 70.6K
- OLMA 532.6K
- Earning Date
- BWAY 08-13-2025
- OLMA 08-11-2025
- Dividend Yield
- BWAY N/A
- OLMA N/A
- EPS Growth
- BWAY 515.14
- OLMA N/A
- EPS
- BWAY 0.11
- OLMA N/A
- Revenue
- BWAY $46,084,000.00
- OLMA N/A
- Revenue This Year
- BWAY $341.83
- OLMA N/A
- Revenue Next Year
- BWAY $23.42
- OLMA N/A
- P/E Ratio
- BWAY $52.60
- OLMA N/A
- Revenue Growth
- BWAY 26.50
- OLMA N/A
- 52 Week Low
- BWAY $7.06
- OLMA $2.86
- 52 Week High
- BWAY $15.61
- OLMA $13.93
- Technical
- Relative Strength Index (RSI)
- BWAY 78.88
- OLMA 63.92
- Support Level
- BWAY $14.33
- OLMA $5.34
- Resistance Level
- BWAY $15.00
- OLMA $5.78
- Average True Range (ATR)
- BWAY 0.56
- OLMA 0.34
- MACD
- BWAY 0.33
- OLMA 0.05
- Stochastic Oscillator
- BWAY 90.26
- OLMA 85.90
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.